glp-1 food industry impact news today Ozempic Users Spending Less on Restaurants & Food Delivery Consumers' Expectations about GLP-1 Drugs

Made in the USA in an FDA-registered, GMP-certified facility and 3rd-party tested for quality

Learn More About Semaglutide & Tirzepatide at Our Med Spa in Frisco

GLP-1 medications can slow digestion, making your gut more sensitive to fermentable carbohydrates (FODMAPs) that cause gas, bloating, and discomfort

The newly approved medication is intended for people with MASH with moderate to advanced fibrosis - when patients are said to be on the cusp of cirrhosis

Innovative pharmacological options are required to cope with the global diabesity pandemic

Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA